Drug Investigation to Dampen the Comorbidity of Rheumatoid Arthritis and Osteoporosis via Molecular Docking Test

Drug Investigation to Dampen the Comorbidity of Rheumatoid Arthritis and Osteoporosis via Molecular Docking Test

At present, most rheumatoid arthritis (RA) patients are at risk of osteoporosis (OP), which is increased by 1.5 times compared to non-RA individuals. Hence, we investigated overlapping targets related directly to the occurrence and development of RA and OP through public databases (DisGeNET, and OMI...

Full description

Bibliographic Details
Main Authors: Ki-Kwang Oh, Md. Adnan, Dong-Ha Cho
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Current Issues in Molecular Biology
Subjects:
rheumatoid arthritis
osteoporosis
comorbidity
interleukin 6
MD2-TLR4-IN-1
Online Access:https://www.mdpi.com/1467-3045/44/3/69

Internet

https://www.mdpi.com/1467-3045/44/3/69

Similar Items